CD8A and neoplasm: However, in the present study, CD8 tumor-infiltrating T cells, in addition to PD-1, expressed high level of other activation markers, such as T-bet, granzyme B and ki67 suggestive of their activated, not-exhausted, state, sufficient for the systemic anti-tumor immune response and therefore not in need of immune checkpoint blockade.